PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Activity

114 hedge funds and large institutions have $599M invested in Phathom Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 21 reducing their positions, and 17 closing their positions.

Holders
114
Holders Change
–
Holders Change %
0%
% of All Funds
1.66%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.15%
New
18
Increased
48
Reduced
21
Closed
17
Calls
$5.18M
Puts
$606K
Net Calls
+$4.57M
Net Calls Change
+$4.75M

Top Buyers

1
PCM
1
Portolan Capital Management
Massachusetts
$11.6M
2
Jennison Associates
2
Jennison Associates
New York
$28.4M
3
Morgan Stanley
3
Morgan Stanley
New York
$7.85M
4
GGHC
4
Gilder Gagnon Howe & Co
New York
$15.2M
5
CC
5
Checkpoint Capital
California
$9.01M

Top Sellers

1
TPC
1
Takeda Pharmaceutical Company
Japan
$16M
2
OCA
2
Octagon Capital Advisors
New York
$0
3
6CM
3
683 Capital Management
New York
$14.4M
4
Millennium Management
4
Millennium Management
New York
$0
5
NM
5
Newtyn Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FLSM
1
Frazier Life Sciences Management
California
$104M 10,109,279 – –
MVM
2
Medicxi Ventures Management
Jersey
$76.9M 7,464,572 – –
CG
3
Carlyle Group
District of Columbia
$35.8M 3,496,808 – –
Invesco
4
Invesco
Georgia
$32.4M 3,143,452 -16,337 -0.5%
BlackRock
5
BlackRock
New York
$30.1M 2,926,373 +180,993 +7%
Jennison Associates
6
Jennison Associates
New York
$28.4M 2,757,579 +1,109,882 +67%
Ensign Peak Advisors
7
Ensign Peak Advisors
Utah
$23.1M 2,244,828 -35,172 -2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$22.8M 2,211,755 +232,642 +12%
NMC
9
NEA Management Company
Maryland
$20.2M 1,960,169 – –
APM
10
Avidity Partners Management
Texas
$16.7M 1,620,000 -115,000 -7%
TPC
11
Takeda Pharmaceutical Company
Japan
$16M 1,557,063 -1,596,154 -51%
GGHC
12
Gilder Gagnon Howe & Co
New York
$15.2M 1,472,259 +454,642 +45%
6CM
13
683 Capital Management
New York
$14.4M 1,400,000 -250,000 -15%
PCM
14
Portolan Capital Management
Massachusetts
$11.6M 1,130,089 +1,130,089 New
CC
15
Checkpoint Capital
California
$9.01M 875,000 +429,839 +97%
PBM
16
Propel Bio Management
California
$8.96M 869,927 – –
DC
17
Decheng Capital
California
$8.76M 850,000 – –
KCM
18
Kennedy Capital Management
Missouri
$8.56M 830,906 +258,570 +45%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$8.3M 806,047 +54,668 +7%
WP
20
Woodline Partners
California
$8.1M 785,990 +219,551 +39%
State Street
21
State Street
Massachusetts
$8.09M 785,249 +68,048 +9%
Morgan Stanley
22
Morgan Stanley
New York
$7.85M 762,597 +525,437 +222%
CP
23
Catalys Pacific
Japan
$7.44M 721,962 – –
GKIM
24
GW&K Investment Management
Massachusetts
$6.19M 600,443 +32,417 +6%
GTC
25
Ghost Tree Capital
New York
$6.18M 600,000 +115,000 +24%
1
2 3 4 5